ALLR - Cash Flow Statement - Allarity Therapeutics, Inc.

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015	Dec-2014	Dec-2013
OPERATING CASH FLOW
Net Income	(11.9)	(16.1)	(26.6)	(5.1)	(14.4)	(2.3)	(4.9)	(3.7)	(1.1)	68.7 K	81.2 K
Depreciation & Amortization	37 K	60 K	0.1	46 K	51 K	32.5 K	8.7 K	0.3	0.3	0	0
Deferred Income Tax	97 K	(1.6)	20 K	(1.3)	(3.8)	0	0	0	0	0	0
Stock Based Compensation	71 K	1.8	6.4	0.6	0.3	0.2	2.3	0	0	0	0
Other Operating Activities	(4.3)	(0.6)	(0.5)	(2.0)	5.6	(2.5)	1.0	(0.6)	(0.4)	68.7 K	81.2 K
Change in Working Capital	3.4	(0.3)	5.6	0.4	2.1	0.3	0.2	25.9 K	(0.7)	0	0
Cash From Operations	(12.7)	(16.8)	(15.1)	(7.3)	(10.1)	(4.2)	(1.3)	(4.0)	(2.0)	0	0
INVESTING CASH FLOW
Capital Expenditures	0	18 K	0	3 K	8 K	5.68 K	0	77.8 K	0	0	0
Other Items	0	0.8	1.0	0	0.2	1.5	(0.1)	(0.1)	1.7	0	0
Cash From Investing Activities	0	0.8	1.0	3 K	0.2	1.5	(0.1)	(0.2)	1.7	0	0
FINANCING CASH FLOW
Common Stock Repurchased	(6.7)	(1.5)	0	0	0	0	0	0	0	0	0
Total Debt Repaid	(2.6)	1.0	1.0	2.6	3.5	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0
Other Financing Activities	(3.3)	(2.3)	0.7	(0.2)	(5.9)	2.4	1.2	4.3	3.8	0	0
Cash From Financing Activities	11.0	(1.3)	33.8	6.0	11.2	2.4	1.2	4.3	3.8	0	0
CHANGE IN CASH
Net Change In Cash	(1.9)	(17.5)	19.3	(1.2)	1.3	(0.3)	(1.5)	2.1	0	0	0
FREE CASH FLOW
Free Cash Flow	(12.7)	(16.8)	(15.1)	(7.3)	(10.1)	(4.2)	(1.3)	(4.1)	(2.0)	0	0

Free